| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.74▼ | 1.74▼ | 1.77▼ | 1.74▼ | 1.67▲ |
| MA10 | 1.77▼ | 1.77▼ | 1.77▼ | 1.73▲ | 1.62▲ |
| MA20 | 1.74▼ | 1.73▼ | 1.71▼ | 1.68▲ | 1.56▲ |
| MA50 | 1.66▼ | 1.66▼ | 1.64▲ | 1.61▲ | 1.34▲ |
| MA100 | 1.60▲ | 1.58▲ | 1.59▲ | 1.56▲ | 1.71▲ |
| MA200 | 1.56▲ | 1.56▲ | 1.56▲ | 1.41▲ | 2.29▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.015▼ | -0.013▼ | -0.005▼ | 0.004▲ | 0.015▲ |
| RSI | 38.088▼ | 40.486▼ | 43.047▼ | 62.232▲ | 67.385▲ |
| STOCH | 51.515 | 51.515 | 76.929 | 63.750 | 84.655▲ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -34.722 | -20.000▲ |
| CCI | -242.902▼ | -136.532▼ | -113.644▼ | 51.914 | 183.977▲ |
|
Friday, November 21, 2025 05:31 AM
LAVA Therapeutics ( ($LVTX) ) just unveiled an update. LAVA Therapeutics announced that following the expiration of a subsequent offering period ...
|
|
Friday, November 21, 2025 04:50 AM
XOMA Royalty (XOMA) completed its previously announced acquisition of all the outstanding common shares of LAVA Therapeutics (LVTX) with a nominal ...
|
|
Friday, November 21, 2025 04:47 AM
Advisors XOMA Royalty was represented by Gibson, Dunn & Crutcher LLP and Loyens & Loeff N.V, who acted as U.S. and Dutch legal advisors, respectively. Leerink Partners acted as exclusive financial ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/11/25 | 1.74 | 1.74 | 1.74 | 1.74 | 0 |
| 26/11/25 | 1.74 | 1.74 | 1.74 | 1.74 | 0 |
| 25/11/25 | 1.74 | 1.74 | 1.74 | 1.74 | 0 |
| 24/11/25 | 1.74 | 1.74 | 1.74 | 1.74 | 0 |
| 21/11/25 | 1.74 | 1.74 | 1.74 | 1.74 | 0 |
| 20/11/25 | 1.81 | 1.82 | 1.62 | 1.74 | 285,521 |
| 19/11/25 | 1.76 | 1.82 | 1.745 | 1.81 | 328,713 |
| 18/11/25 | 1.63 | 1.825 | 1.63 | 1.78 | 543,725 |
| 17/11/25 | 1.655 | 1.67 | 1.60 | 1.66 | 90,847 |
| 14/11/25 | 1.68 | 1.68 | 1.62 | 1.65 | 46,538 |
|
|
||||
|
|
||||
|
|